DEMETRIOU STEVEN J.

AMTM Executive Chair Steven Demetriou buys 100,000 shares at $20.81; stock down 40.7% from 52-week high.

Demetriou purchased 100,000 shares (100.0K shares) at $20.81 on 2025-02-12, increasing his holdings to 620,893 shares (620.9K shares), a 19.2% increase in his stake. This open-market purchase by the Executive Chair occurs against a backdrop of significant stock weakness: the stock is trading at $19.80, down 40.7% from its 52-week high of $33.40 and down 15.6% over the prior 30 days. The company reported latest quarter revenue of $3,416,000,000.00 ($3.4B) with net income of $12,000,000.00 ($12.0M), though notably the company was unprofitable over its most recent full fiscal year. Demetriou's prior open-market buy showed a 90-day return of +23.1%, but his cross-ticker track record on prior sells achieved a 75.00% well-timed rate with a -4.3% average 90-day return, indicating historical execution discipline. The timing of this substantial purchase during a period of depressed valuation and negative momentum warrants attention to whether management views current prices as a dislocation opportunity.

Director DEMETRIOU STEVEN J. purchased 6,000 shares of ACA at $87.70; holdings now 9,943 shares (+152.2%)

DEMETRIOU STEVEN J., a director at Arcosa Inc., purchased 6,000 shares at $87.70 on 2024-09-12, increasing his post-transaction holdings to 9,943 shares from 3,943 shares—a 152.2% increase in his stake. The transaction occurred at a price $0.07 below the current market level of $87.77, placing the purchase near the top of the 52-week range ($65.14–$92.91) at just 5.5% below the 52-week high. His cross-ticker track record shows 4 prior sells with a 90d well-timed rate of 66.67%, indicating above-average execution on prior dispositions, though this history is not ticker-specific to ACA. At a P/E of 29.06 and recent revenue growth of 2.9%, the stock trades at a material valuation multiple; the purchase at elevated price levels in a narrow recent range (up 5.2% in 30 days, 5.0% in 90 days) occurs in a fundamentally modest-growth environment.

Executive Chair Demetriou sells 7,000 J shares at $146.88; stock now $140.13 (down 8.8% from 52-week high).

Steven J. Demetriou, Executive Chair, sold 7,000 shares at $146.88 on 2024-08-01 for $1,028,160.00, reducing his holdings to 527,138 shares. The transaction represents a -1.3% reduction in his pre-transaction position. The sale occurred near the 52-week high, with the stock subsequently declining to a current price of $140.13 (-8.8% from the 52-week high). Examining his prior trades at Jacobs Solutions specifically, Demetriou's timing pattern shows 2 of 3 prior sells achieved negative 90-day returns, indicating a modest track record of selling before declines at this ticker. However, the cross-ticker track record shows average 90-day returns of -4.5% post-sale with a 66.67% well-timed rate, which aligns with the subsequent underperformance observed after this transaction.